Aytu BioPharma (NASDAQ:AYTU) Stock Passes Below Fifty Day Moving Average – Should You Sell?

Shares of Aytu BioPharma, Inc. (NASDAQ:AYTU) crossed below its 50-day moving average during trading on Friday . The stock has a 50-day moving average of $1.59 and traded as low as $1.34. Aytu BioPharma shares last traded at $1.35, with a volume of 64,208 shares traded.

Aytu BioPharma Stock Performance

The firm’s 50-day simple moving average is $1.59 and its two-hundred day simple moving average is $1.96. The company has a market cap of $8.33 million, a PE ratio of -0.93 and a beta of -1.45. The company has a current ratio of 0.98, a quick ratio of 0.81 and a debt-to-equity ratio of 0.32.

Aytu BioPharma (NASDAQ:AYTU) last released its earnings results on Wednesday, February 12th. The company reported ($0.28) earnings per share (EPS) for the quarter. Aytu BioPharma had a negative net margin of 7.62% and a negative return on equity of 19.30%.

Hedge Funds Weigh In On Aytu BioPharma

A hedge fund recently raised its stake in Aytu BioPharma stock. Stonepine Capital Management LLC grew its position in Aytu BioPharma, Inc. (NASDAQ:AYTU) by 6.0% in the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 500,958 shares of the company’s stock after buying an additional 28,489 shares during the quarter. Aytu BioPharma accounts for 0.7% of Stonepine Capital Management LLC’s holdings, making the stock its 25th largest holding. Stonepine Capital Management LLC owned approximately 8.15% of Aytu BioPharma worth $1,177,000 at the end of the most recent reporting period. Institutional investors own 33.49% of the company’s stock.

Aytu BioPharma Company Profile

Aytu Biopharma, Inc is a specialty pharmaceutical company, which engages in identifying, acquiring, and commercializing novel products. It operates through the Rx and Consumer Health segments. The RX segment consists of various prescription pharmaceutical products sold through third parties. The Consumer Health segment includes various consumer health products sold directly to consumers.